Physician profile
Robert Toledo
NPI 1598723389
$761.41
in general payments reported to CMS, 2019-2025
18 companies · $156 in 2025
The $156 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $91.22 · 2020: $45.34 · 2021: $167 · 2022: $73.40 · 2023: $143 · 2024: $86.28 · 2025: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $385.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $384.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $151.51 | 2019-2025 | Aptima |
| Abbvie INC. | $114.70 | 2019-2024 | Vraylar |
| Orexo US, INC. | $74.88 | 2021-2022 | |
| Organon LLC | $61.81 | 2022-2023 | Nexplanon |
| Astellas Pharma US INC | $38.11 | 2023 | Veozah |
| Shield Therapeutics INC | $37.88 | 2024-2025 | |
| Exact Sciences Corporation | $34.39 | 2025 | Cologuard Collection Kit |
| Optumhealth Care Solutions, LLC | $30.89 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Gilead Sciences, INC. | $30.71 | 2024 | |
| Daiichi Sankyo INC. | $29.70 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $26.46 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $22.00 | 2021 | |
| Therapeuticsmd, INC. | $21.18 | 2021 | |
| Intra-Sana Laboratories | $20.29 | 2025 | Glycate, Reltone 400 Mg, Reltone 200 Mg |
| Becton, Dickinson and Company | $20.18 | 2023 | Bd Onclarity |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company Ltd. | $18.14 | 2022 | |
| Sage Therapeutics, LLC | $15.12 | 2025 | Zurzuvae |
| Merck Sharp & Dohme LLC | $13.46 | 2024 | Gardasil 9, Gardasil |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Toledo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.